← Back to Patent Explorer
US4889844A Expired / Lapsed US ⏱️ 0.0 years remaining

Fructose containing wound healing preparation

Assignee: LANGE ASSOCIATES LP
•
Filing: 1987-10-16
•
Granted: 1989-12-26
•
Expires: 2007-10-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to a composition comprising at least one pharmaceutically acceptable monosaccharide containing from about 3 to 7 carbon atoms and a pharmaceutically acceptable film forming agent.

Inventors

  • 👤 Anthony N. Silvetti, Sr.
  • 👤 Anthony N. Silvetti, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 20:27
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004; Y; Y10; Y10S; Y10S424/00; Y10S424/13

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 41 words
A method of treating wounds in a host in need of such treatment which comprises contacting the wound, for a period of time sufficient to initiate wound healing, with a therapeutically effective amount of a composition comprising fructose and starch hydrolysate.
Claim 2
Independent Claim 41 words
A method of treating wounds in a host in need of such treatment which comprises contacting the wound, for a period of time sufficient to initiate wound healing, with a therapeutically effective amount of a composition comprising fructose and starch hydrolysate.
Claim 3
Dependent Claim 20 words
The method in accordance with claim 1 wherein said starch hydrolysate has a dextrose equivalent of not more than 85.
Claim 4
Dependent Claim 20 words
The method in accordance with claim 2 wherein said starch hydrolysate has a dextrose equivalent of not more than 40.
Claim 5
Dependent Claim 25 words
The method in accordance with claim 3 wherein said dextrose equivalent of said starch hydrolysate is in the range of between about 7.5 and 40.
Claim 6
Dependent Claim 25 words
The method in accordnace with claim 4 wherein said dextrose equivalent of said starch hydrolysate is in the range of between about 7.5 and 30.
Claim 7
Dependent Claim 25 words
The method in accordance with claim 5 wherein said dextrose equivalent of said starch hydrolysate is in the range of between about 10 and 20.
Claim 8
Dependent Claim 24 words
The method in accordance with claim 6 wherein said starch hydrolysate is a maltodextrin having a dextrose equivalent of between about 13 and 17.
Claim 9
Dependent Claim 27 words
The method in accordance with claim 1 wherein said fructose is present in an amount of between about 0.01 to about 50% by weight of the composition.
Claim 10
Dependent Claim 27 words
The method in accordance with claim 8 wherein said fructose is present in an amount of between about 5 to about 30% by weight of the composition.
Claim 11
Dependent Claim 19 words
The method in accordance with claim 1 wherein the composition comprises ascorbic acid or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim 20 words
The method in accordance with claim 1 wherein the composition comprises alpha-ketoglutaric acid or pharmaceutically acceptable salts of alpha-ketoglutaric acid.
Claim 13
Dependent Claim 16 words
The method in accordance with claim 1 wherein the composition comprises at least one amino acid.
Claim 14
Dependent Claim 44 words
The method in accordance with claim 12 wherein the amino acid is selected from the group consisting of isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophane, valine, tyrosine, alanine, arginine, glycine, proline, histidine, serine, asparagine, aspartic acid, cysteine, cystine, glutamine, glutamic acid, and mixtures thereof.
Claim 15
Dependent Claim 19 words
The method in accordance with claim 13 wherein said amino acid is glycine, proline or lysine or mixtures thereof.
Claim 16
Dependent Claim 39 words
The method in accordance with claim 1 wherein the composition comprises at least one pharmaceutically acceptable metal salt selected from the group consisting of ferrous salts calcium salts, silver salts, magnesium salts, manganese salts, copper salts and selenium salts.
Claim 17
Dependent Claim 18 words
The method in accordance with claim 15 wherein said salt is ferrous sulfate, ferrous gluconate or ferrous chloride.
Claim 18
Dependent Claim 13 words
The method in accordance with claim 16 wherein said salt is ferrous sulfate.
Claim 19
Dependent Claim 18 words
The method in accordance with claim 1 wherein the composition comprises an iodine salt, elemental iodine or PVP-iodine.

References Cited (Backward Citations)

US3859436A Cited
US3812252A Cited
US4401651A Cited
US4414202A Cited
EP0060553A1 Cited
EP0103878A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-12-25 1993-06-26 1993-12-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-12-25 1997-06-26 1997-12-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-12-25 2001-06-26 2001-12-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag